Bristol Myers Squibb (BMY) Goodwill (2009 - 2026)
Bristol Myers Squibb (BMY) reported Goodwill of $21.7 billion for Q1 2026, little changed year-over-year from $21.7 billion in Q1 2025, and little changed quarter-over-quarter from $21.8 billion in Q4 2025.
Bristol Myers Squibb (BMY) Goodwill (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (BMY) has 18 years of Goodwill data on file, last reported at $21.7 billion in Q1 2026.
- Goodwill for Q1 2026 came in at $21.7 billion, changed 0.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.7 billion (changed 0.01% YoY), and the FY2025 annual result was $21.8 billion, changed 0.16% from the prior year.
- Goodwill steadied at $21.7 billion in Q1 2026 per BMY's latest filing, from $21.8 billion in the prior quarter.
- Over five years, Goodwill peaked at $21.8 billion in Q2 2025 and troughed at $20.4 billion in Q2 2022.
- A 5-year average of $21.4 billion and a median of $21.7 billion in 2024 frame the typical range for Goodwill.
- The sharpest annual moves came in 2022 and 2023: Goodwill dropped 0.4% in 2022, then increased 3.51% in 2023.
- A 5-year view of Goodwill shows it stood at $21.1 billion in 2022, then increased by 0.09% to $21.2 billion in 2023, then grew by 2.6% to $21.7 billion in 2024, then climbed by 0.16% to $21.8 billion in 2025, then fell by 0.06% to $21.7 billion in 2026.
- Business Quant data shows BMY's Goodwill at $21.7 billion in Q1 2026, $21.8 billion in Q4 2025, and $21.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.74 Bn |
| Dec 31, 2025 | 21.75 Bn |
| Sep 30, 2025 | 21.75 Bn |
| Jun 30, 2025 | 21.78 Bn |
| Mar 31, 2025 | 21.74 Bn |
| Dec 31, 2024 | 21.72 Bn |
| Sep 30, 2024 | 21.75 Bn |
| Jun 30, 2024 | 21.73 Bn |
| Mar 31, 2024 | 21.74 Bn |
| Dec 31, 2023 | 21.17 Bn |
| Sep 30, 2023 | 21.15 Bn |
| Jun 30, 2023 | 21.16 Bn |
| Mar 31, 2023 | 21.16 Bn |
| Dec 31, 2022 | 21.15 Bn |
| Sep 30, 2022 | 21.11 Bn |
| Jun 30, 2022 | 20.45 Bn |
| Mar 31, 2022 | 20.50 Bn |
| Dec 31, 2021 | 20.50 Bn |
| Sep 30, 2021 | 20.52 Bn |
| Jun 30, 2021 | 20.53 Bn |